PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Argutus Medical Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Argutus Medical Receives ISO 13485 Quality Management System Certification - Argutus Medical Ltd, an EKF Diagnostics Company announces that its Quality Management System has received ISO 13485:2003 certification. The assessment was carried out by the notified body BSI (British Standards Institute) - ArgutusMed.com
Argutus Medical Receives ISO 13485 Quality Management System Certification

 

NewswireToday - /newswire/ - Dublin, Ireland, 2012/09/04 - Argutus Medical Ltd, an EKF Diagnostics Company announces that its Quality Management System has received ISO 13485:2003 certification. The assessment was carried out by the notified body BSI (British Standards Institute) - ArgutusMed.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Argutus Medical Ltd, an EKF Diagnostics Company (AIM: EKF), is pleased to announce that it’s Quality Management System has been certified as fulfilling the requirements of ISO 13485:2003. The scope of this certification covers the Design, Development, manufacture and distribution of in-vitro diagnostic biomarkers to assess organ damage.

The assessment of Argutus Medical’s Quality Management System was performed by British Standards Institute (BSI), a world leader among notified bodies.

Joe Keenan, General Manager at Argutus Medical welcomed this significant landmark and said that the completion of the audits is evidence of the company’s persistence in maintaining only the highest quality products. "At Argutus, we are constantly striving to uphold the highest quality standards for our company and our products," he said. "Earning these certifications shows that our pursuit of quality is paying off and it will benefit our customers greatly."

As a globally recognised quality management system certification for medical devices and related services, receipt of ISO 13485 certification confirms Argutus Medical’s ongoing commitment to meet the requirements of its customers and regulatory bodies.

About Argutus Medical Ltd, an EKF Diagnostics Company

Argutus Medical Ltd (argutusmed.com) is a world leader in the development, manufacture and supply of a variety of test kits for the early detection of injury to organs such as the kidney and liver. Argutus Medical is based in Dublin, Ireland and since 2010 has been part of EKF Diagnostics Holdings plc (AIM:EKF) a publicly listed Healthcare company that is headquartered in Cardiff, Wales, UK.

EKF Diagnostics Holdings plc specialises in the development, manufacture and distribution of point of care analysers for hemoglobin, HbA1c, glucose, lactate as well as a range of clinical chemistry products and biomarker-based ELISA & rapid tests. EKF Diagnostics has nine sites in six countries and employs 295 people as of 31 December 2011.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Argutus Medical Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Argutus Medical Receives ISO 13485 Quality Management System Certification

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Joe Keenan - ArgutusMed.com 
+353 1 670 8576 info[.]argutusmed.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Argutus Medical Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Argutus Medical Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)